Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Hanseníase e avaliação neurológica simplificada: conhecimento de profissionais da atenção primária à saúde

Freitas Maia AC, Tronconi IC, Sabeh ACB, et al. Universidad el Bosque. Revista Colombiana de Enfermería. 2024; 23 (1) : 1-14.
Download PDF
Publication

Impacto clínico das internações por sequelas de Hanseníase: uma análise epidemiológica abrangente

Igarashi ÁT, Gonzaga PDV, Lana SC, et al. South Florida Publishing LLC. Brazilian Journal of Health Review. 2024; 7 (5) : 1-10.
Download PDF
Publication

Unveiling inflammatory biomarkers in multibacillary leprosy: the role of lymphocyte-platelet ratio in predicting leprosy reactions

Trindade LC, da Paz AR, da Silveira Mendes M, et al. Springer Science and Business Media LLC. Archives of Dermatological Research. 2024;
Publication

Risk Factors for Psychological Impact and Stigma Among Leprosy Patients: A Systematic Review

Rasyidi N, Yusuf A, Tristiana D. Indonesian Journal of Global Health Research. 2024;
Download PDF
Publication

Incapacidades na hanseníase: uma revisão da literatura

Fadel SR, Marques BG, Cajado JB, et al. Editora Científica Digital. Open Science Research XVI. 2024;
Download PDF
Publication

IL-22 in Mycobacterium leprae-induced Nerve injury.

Geng H, Bao F, Wang C, et al. The British journal of dermatology. 2024;
Publication

Frequency and Factors Associated with Disabilities among Leprosy Patients Admitted to the Kindia Disability Prevention and Physical Rehabilitation Centre (Pirp) in Guinea from 2017 to 2021

Ibrahima Sory SS, Sidikiba S, Delphin K, et al. MDPI AG. Tropical Medicine and Infectious Disease. 2024; 9 (10) : 1-9.
Download PDF
Publication

Burden of leprosy and associated risk factors for disabilities in Tanzania from 2017 to 2020

Mrema G, Hussein A, Magoge W, et al. Public Library of Science (PLoS). PLOS ONE. 2024; 19 (10) : 1-13.
Download PDF
Publication

Avaliação do grau de incapacidade neurofuncional dos pacientes com diagnóstico de Hanseníase/ Assessment of the degree of neurofunctional disability in patients diagnosed with leprosy

Oliveira PDS, Silva AMFD, Neto LRDS, et al. South Florida Publishing LLC. Brazilian Journal of Health Review. 2021; 4 (4) : 15870-15887.
Download PDF
Publication

Lepra: enfermedad reemergente

Hincapie DAF, Rozo EFM, Agudelo LG, et al. Dermatology Mexican Megazine. 2024;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 7
  • Next page ››
Subscribe to Disability

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD